Clinical Trial

IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

Name: IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies — clinical trial record (NCT07574346)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-center, open-label, exploratory clinical study to evaluate the efficacy and safety of IASO207 Injection in patients with Relapsed/Refractory B-cell Malignancies。

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-19

Trial Details

NCT Number	NCT07574346
Lead Sponsor	Peking University People's Hospital
Conditions	Malignancies
Enrollment	18 participants
Start Date	2026-05-29
Primary Completion	2029-04-30 (estimated)
Study Completion	2042-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-18